At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TRVN Trevena
Closed 05-14 16:00:00 EDT
0.4180
+0.0001
+0.02%
盘后0.4300
+0.0120+2.87%
18:13 EDT
High0.4300
Low0.3900
Vol128.64K
Open0.4300
D1 Closing0.4179
Amplitude9.57%
Mkt Cap7.66M
Tradable Cap7.57M
Total Shares18.32M
T/O51.73K
T/O Rate0.71%
Tradable Shares18.10M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Trevena Inc expected to post a loss of 47 cents a share - Earnings Preview
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV250, a G protein biased delta-opioid receptor agonist for the treatment of acute migraine; TRV734, a small molecule G protein biased ligand of the MOR for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is based in Chesterbrook, Pennsylvania.